郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Design and synthesis of piperazinylpyridine derivatives as novel 5-HT1A agonists/5-HT3 antagonists for the treatment of irritable bowel syndrome (IBS).

期刊:Chemical & pharmaceutical bulletin发表年份:2009作者:Akira Asagarasu; Teruaki Matsui; Hiroyuki Hayashi; Satoru Tamaoki; Yukinao Yamauchi; Michitaka Sato

药效评价Use of aequorin for G protein-coupled receptor hit identification and compound profiling.

期刊:Methods in molecular biology (Clifton, N.J.)发表年份:2009作者:Stephen J Brough; Parita Shah

药效评价Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.

期刊:ChemMedChem发表年份:2009作者:Marc Vendrell; Aroa Soriano; Vicent Casadó; José Luis Díaz; Rodolfo Lavilla; Enric I Canela; Carme Lluís; Rafael Franco; Fernando Albericio; Miriam Royo

药效评价Highly potent 4-amino-indolo[2,3-c]azepin-3-one-containing somatostatin mimetics with a range of sst receptor selectivities.

期刊:Journal of medicinal chemistry发表年份:2009作者:Debby Feytens; Magali De Vlaeminck; Renzo Cescato; Dirk Tourwé; Jean Claude Reubi